Dalamaga, Maria
Christodoulatos, Gerasimos Socrates
Karampela, Irene
Vallianou, Natalia
Apovian, Caroline M.
Article History
Accepted: 14 April 2021
First Online: 28 April 2021
Declarations
: CMA reports receiving personal fees from Nutrisystem, Zafgen, Sanofi-Aventis, Orexigen, EnteroMedics, GI Dynamics, Scientific Intake, Gelesis, Novo Nordisk, SetPoint Health, Xeno Biosciences, Rhythm Pharmaceuticals, Eisai, and Takeda outside of the funded work. CMA reports receiving grant funding from Aspire Bariatrics, GI Dynamics, Orexigen, Takeda, the Vela Foundation, Gelesis, Energesis, Coherence Lab, and Novo Nordisk outside of the funded work. CMA reports past equity interest in ScienceSmart, LLC. No other disclosures were reported.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: All authors declare that they have no conflict of interest.
Free to read: This content has been made available to all.